“foundation-medicine” Archives

Entry Author Date Location
Bought By Utah Rival Tute, Former Genomics High Flyer Knome Bows Out 11/02/15 Boston
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
Boston’s Life Science Disruptors 2015: The Photos 10/06/15 Boston
Five Takeaways From “Boston’s Life Science Disruptors” 10/02/15 Boston
Agenda Posted for Boston’s Life Science Disruptors on Sept. 30 09/22/15 Boston
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30 09/14/15 Boston
Carbon3D Gains Google’s $100M Backing for 3-D Printing Tech 08/20/15 San Francisco
To Fight “Superbugs,” Roche Shells Out $190M For Bay Area’s GeneWEAVE 08/13/15 San Francisco
FDA Taps DNAnexus to Build Platform for Crowdsourcing Diagnostics 08/05/15 National
In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business? 08/04/15 National
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
What’s Hot in Boston Biotech: The Photos 04/15/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
10X Genomics Emerges With $80M and Toaster-Sized Sequencer Upgrade 01/12/15 San Francisco
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Data Companies Carve Out Niche In DNA Test Interpretation 11/21/14 Boston
T2 Biosystems Sputters Through IPO Queue, Raises $57M 08/07/14 Boston
Two San Francisco Startups Sharing In Third Rock’s Rich Third Fund 04/24/14 San Francisco
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
Tests for Tumor DNA in Blood May Yield New Ways to Hit Cancer 02/26/14 San Francisco
Molecular Diagnostics Are in a Rut. The Industry Needs the FDA 02/17/14 National
Fresh from IPO, Five Prime Advances Arthritis and Cancer Drugs 12/19/13 San Francisco
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
Foundation’s IPO Isn’t Bubbly, It’s a Jolt for Genomic Diagnostics 09/25/13 Boston
Foundation Medicine, Ophthotech Both Find Open Wallets on Wall Street 09/25/13 Boston
Page 1 of 3 next page »